No results for ‘’
Medi Caps Ltd
NSE: MEDICAPS BSE: 523144
â‚ą26.57
(1.56%)
Wed, 09 Sept 2026, 08:54 pm
Market Cap (in Cr)32.23
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KMedi Caps Analysis
dividend
- Unable to calculate sustainability of dividends as Medi-Caps has not reported any payouts.
- Unable to evaluate Medi-Caps's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Medi-Caps's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Medi-Caps is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Medi-Caps has been profitable on average in the past, therefore cash runway is not a concern.
- Medi-Caps has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (3094.6%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 417.7x debt.
- Medi-Caps's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (3.4% vs 0.1% today).
- Medi-Caps's level of debt (0.1%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The average tenure for the Medi-Caps board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- Alok's remuneration is about average for companies of similar size in India.
- Alok's compensation has been consistent with company performance over the past year, both up more than 20%.
- The tenure for the Medi-Caps management team is about average.
misc
- Medi-Caps is not covered by any analysts.
- Medi-Caps has significant price volatility in the past 3 months.
past
- Unable to compare Medi-Caps's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Medi-Caps does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
- It is difficult to establish if Medi-Caps has efficiently used its assets last year compared to the IN Packaging industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Medi-Caps improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Medi-Caps has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Medi-Caps's 1-year growth to the IN Packaging industry average as it is not currently profitable.
value
- Medi-Caps's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Medi-Caps's share price is below the future cash flow value, and at a substantial discount (> 40%).
- Medi-Caps is good value based on assets compared to the IN Packaging industry average.
- Medi-Caps is loss making, we can't compare its value to the IN Packaging industry average.
- Medi-Caps is loss making, we can't compare the value of its earnings to the India market.
- 523144 underperformed the Packaging industry which returned -14.7% over the past year.
- 523144 underperformed the Market in India which returned -14.5% over the past year.
- BSE:523144 is up 4.4% underperforming the Packaging industry which returned 6.3% over the past month.
- BSE:523144 is up 4.4% underperforming the market in India which returned 8% over the past month.